The duration of immune protection against SAR-CoV-2 reinfection in patients who have recovered from COVID19 is a critical unanswered question. To determine the long-term clinical and virologic outcome in patients who have recovered from COVID-19, we prospectively followed 220 patients with COVID-19 admitted to Renmin Hospital of Wuhan University between 15 January and 15 February 2020 who recovered and were followed up until 15 July 2020. Throat swab SARS-CoV-2 RNA was tested regularly during hospitalization and follow-up using reverse transcription polymerase chain reaction (RT-PCR).
展开▼